Atilla, P. A. Et Al. 2018. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.. Hematology/oncology and stem cell therapy , vol.11, no.1 , 13-17.

Atilla, P. A., Atilla, E., CİVRİZ BOZDAĞ, S., YÜKSEL, M., TOPRAK, S. K., TOPÇUOĞLU, P., ... DEMİRER, T.(2018). Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.. Hematology/oncology and stem cell therapy , vol.11, no.1, 13-17.

Atilla, Pinar Et Al. "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.," Hematology/oncology and stem cell therapy , vol.11, no.1, 13-17, 2018

Atilla, Pinar A. Et Al. "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.." Hematology/oncology and stem cell therapy , vol.11, no.1, pp.13-17, 2018

Atilla, P. A. Et Al. (2018) . "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.." Hematology/oncology and stem cell therapy , vol.11, no.1, pp.13-17.

@article{article, author={Pinar Ataca Atilla Et Al. }, title={Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.}, journal={Hematology/oncology and stem cell therapy}, year=2018, pages={13-17} }